Impaired CXCR4 expression and cell engraftment of bone marrow-derived cells from aged atherogenic mice

Atherosclerosis

Volumn 219, Issue 1, 2011, Pages 92-99

  Xu, Qiyuan ^a,b   Wang, Jian'An ^a   He, Jinlin ^b   Zhou, Mingsheng ^b,c   Adi, Jennipher ^c   Webster, Keith A ^c   Yu, Hong ^a,b,c  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b South Florida VA Foundation for Research   (United States)

^c UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Age; Bone marrow; CXCR4; Engraftment; Homing; Migration; Progenitor cells; SDF 1; Viability

Indexed keywords

APOLIPOPROTEIN E; ATAXIN 1; CALCIUM; CD34 ANTIGEN; CHEMOKINE RECEPTOR CXCR4; IONOMYCIN; MESSENGER RNA; STROMAL CELL DERIVED FACTOR 1; VASCULOTROPIN RECEPTOR 2;

AGING; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; BONE MARROW CELL; CALCIUM TRANSPORT; CHEMOTAXIS; CORONARY ARTERY DISEASE; DISEASE COURSE; GENE EXPRESSION; HUMAN; HUMAN CELL; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; STEM CELL; WILD TYPE;

AGING; ANIMALS; APOLIPOPROTEINS E; APOPTOSIS; ATHEROSCLEROSIS; BONE MARROW CELLS; CALCIUM; CELL MOVEMENT; CELL SURVIVAL; CHEMOKINE CXCL12; DIET, HIGH-FAT; MICE; MICE, KNOCKOUT; RECEPTORS, CXCR4;

EID: 80054982170     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2011.07.118     Document Type: Article

References (31)

1. Vasa M., Fichtlscherer S., Aicher A., et al. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res 2001, 89:E1-E7.
2. Rauscher F.M., Goldschmidt-Clermont P.J., Davis B.H., et al. Aging, progenitor cell exhaustion, and atherosclerosis. Circulation 2003, 108:457-463.
3. Heiss C., Keymel S., Niesler U., Ziemann J., Kelm M., Kalka C. Impaired progenitor cell activity in age-related endothelial dysfunction. J Am Coll Cardiol 2005, 45:1441-1448.
4. Heeschen C., Lehmann R., Honold J., et al. Profoundly reduced neovascularization capacity of bone marrow mononuclear cells derived from patients with chronic ischemic heart disease. Circulation 2004, 109:1615-1622.
5. Liguori A., Fiorito C., Balestrieri M.L., et al. Functional impairment of hematopoietic progenitor cells in patients with coronary heart disease. Eur J Haematol 2008, 80:258-264.
6. Morrison S.J., Wandycz A.M., Akashi K., Globerson A., Weissman I.L. The aging of hematopoietic stem cells. Nat Med 1996, 2:1011-1016.
7. Askari A.T., Unzek S., Popovic Z.B., et al. Effect of stromal-cell-derived factor 1 on stem-cell homing and tissue regeneration in ischaemic cardiomyopathy. Lancet 2003, 362:697-703.
8. Jin D.K., Shido K., Kopp H.-G., et al. Cytokine-mediated deployment of SDF-1 induces revascularization through recruitment of CXCR4+ hemangiocytes. Nat Med 2006, 12:557-567.
9. Lapidot T. Mechanism of human stem cell migration and repopulation of NOD/SCID and B2mnull NOD/SCID mice. The role of SDF-1/CXCR4 interactions. Ann N Y Acad Sci 2001, 938:83-95.
10. De Falco E., Porcelli D., Torella A.R., et al. SDF-1 involvement in endothelial phenotype and ischemia-induced recruitment of bone marrow progenitor cells. Blood 2004, 104:3472-3482.
11. Seeger F.H., Rasper T., Koyanagi M., Fox H., Zeiher A.M., Dimmeler S. CXCR4 expression determines functional activity of bone marrow-derived mononuclear cells for therapeutic neovascularization in acute ischemia. Arterioscler Thromb Vasc Biol 2009, 29:1802-1809.
12. Foguenne J., Di Stefano I., Giet O., Beguin Y., Gothot A. Ex vivo expansion of hematopoietic progenitor cells is associated with downregulation of alpha4 integrin- and CXCR4-mediated engraftment in NOD/SCID beta2-microglobulin-null mice. Haematologica 2009, 94:185-194.
13. Zhang D., Fan G.-C., Zhou X., et al. Over-expression of CXCR4 on mesenchymal stem cells augments myoangiogenesis in the infarcted myocardium. J Mol Cell Cardiol 2008, 44:281-292.
14. Wu Q., Shao H., Eton D., et al. Extracellular calcium increases CXCR4 expression on bone marrow-derived cells and enhances pro-angiogenesis therapy. J Cell Mol Med 2009, 13:3764-3773.
15. Kahn J., Byk T., Jansson-Sjostrand L., et al. Overexpression of CXCR4 on human CD34+ progenitors increases their proliferation, migration, and NOD/SCID repopulation. Blood 2004, 103:2942-2949.
16. Porecha N.K, English K., Hangoc G., Broxmeyer H.E., Christopherson K.W. Enhanced functional response to CXCL12/SDF-1 through retroviral overexpression of CXCR4 on M07e cells: implications for hematopoietic stem cell transplantation. Stem Cells Dev 2006, 15:325-333.
17. Shao H, Xu Q, Wu Q, et al. Defective CXCR4 expression in aged bone marrow cells impairs vascular regeneration. J Cell Mol Med, in press. doi:10.1111/j.1582-4934.2010.01231.x.
18. Piedrahita J.A., Zhang S.H., Hagaman J.R., Oliver P.M., Maeda N. Generation of mice carrying a mutant apolipoprotein E gene inactivated by gene targeting in embryonic stem cells. Proc Natl Acad Sci U S A 1992, 89:4471-4475.
19. Yoon C.H., Hur J., Park K.W., et al. Synergistic neovascularization by mixed transplantation of early endothelial progenitor cells and late outgrowth endothelial cells: the role of angiogenic cytokines and matrix metalloproteinases. Circulation 2005, 112:1618-1627.
20. Bhakta S., Hong P., Koc O. The surface adhesion molecule CXCR4 stimulates mesenchymal stem cell migration to stromal cell-derived factor-1 in vitro but does not decrease apoptosis under serum deprivation. Cardiovasc Revasc Med 2006, 7:19-24.
21. Orlandi A., Chavakis E., Seeger F., Tjwa M., Zeiher A., Dimmeler S. Long-term diabetes impairs repopulation of hematopoietic progenitor cells and dysregulates the cytokine expression in the bone marrow microenvironment in mice. Basic Res Cardiol 2010, 105(6):703-712.
22. Balestrieri M.L., Lu S.J., de Nigris F., et al. Therapeutic angiogenesis in diabetic apolipoprotein E-deficient mice using bone marrow cells, functional hemangioblasts and metabolic intervention. Atherosclerosis 2010, 209:403-414.
23. Yoder M.C, Ingram D.A. The definition of EPCs and other bone marrow cells contributing to neoangiogenesis and tumor growth: is there common ground for understanding the roles of numerous marrow-derived cells in the neoangiogenic process?. Biochim Biophys Acta (BBA): Rev Cancer 2009, 1796:50-54.
24. Ciriza J., Garcia-Ojeda M.E. Expression of migration-related genes is progressively upregulated in murine Lineage-Sca-1+c-Kit+ population from the fetal to adult stages of development. Stem Cell Res Ther 2010, 1:14.
25. Kucia M., Reca R., Campbell F.R., et al. A population of very small embryonic-like (VSEL) CXCR4+SSEA-1+Oct-4+ stem cells identified in adult bone marrow. Leukemia 2006, 20:857-869.
26. Zhu S., Liu X., Li Y., Goldschmidt-Clermont P.J., Dong C. Aging in the atherosclerosis milieu may accelerate the consumption of bone marrow endothelial progenitor cells. Arterioscler Thromb Vasc Biol 2007, 27:113-119.
27. Wassmann S., Werner N., Czech T., Nickenig G. Improvement of endothelial function by systemic transfusion of vascular progenitor cells. Circ Res 2006, 99:E74-E83.
28. Cola M.S., Gava A.L., Meyrelles S.S., Vasquez E.C. Endothelial dysfunction of resistance vessels in female apolipoprotein E-deficient mice. Lipids Health Dis 2010, 9:51.
29. Al-Shaer M.H., Choueiri N.E., Correia M.L.G., Sinkey C.A., Barenz T.A., Haynes W.G. Effects of aging and atherosclerosis on endothelial and vascular smooth muscle function in humans. Int J Cardiol 2006, 109:201-206.
30. Stolzing A., Jones E., McGonagle D., Scutt A. Age-related changes in human bone marrow-derived mesenchymal stem cells: consequences for cell therapies. Mech Ageing Dev 2008, 129:163-173.
31. Wilson A., Shehadeh L.A., Yu H., Webster K.A. Age-related molecular genetic changes of murine bone marrow mesenchymal stem cells. BMC Genomics 2010, 11:229.